0001213900-25-065334 Sample Contracts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 18th, 2025 • Citius Oncology, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 16, 2025, between Citius Oncology Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT CITIUS ONCOLOGY, Inc.Placement Agent Common Stock Purchase Warrant • July 18th, 2025 • Citius Oncology, Inc. • Pharmaceutical preparations • New York
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [______] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 17, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Citius Oncology, Inc. a Delaware corporation (the “Company”), up to [____] shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and The Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subje
COMMON STOCK PURCHASE WARRANT Citius Oncology, Inc.Common Stock Purchase Warrant • July 18th, 2025 • Citius Oncology, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 17, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Citius Oncology, Inc., a Delaware corporation (the “Company”), up to [______] shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and The Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, sub
CITIUS ONCOLOGY, INC. and EQUINITI TRUST COMPANY, LLC, as Warrant Agent Warrant Agency Agreement Dated as of July 17, 2025 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • July 18th, 2025 • Citius Oncology, Inc. • Pharmaceutical preparations • New York
WARRANT AGENCY AGREEMENT, dated as of July 17, 2025 (“Agreement”), between Citius Oncology, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and Equiniti Trust Company, LLC (the “Warrant Agent”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 18th, 2025 • Citius Oncology, Inc. • Pharmaceutical preparations • New York